Picture EBD Group World of Partnering Opportunities 650x100px

Document › Details

Takeda Pharmaceutical Co. Ltd.. (4/19/18). "Press Release: Takeda Statement Regarding Shire plc [Not for release in any jurisdiction where violation of law]". Cambridge, MA & Osaka.

	Organisation	Takeda Pharmaceutical Co., Ltd. (TSE: 4502)
	Organisation 2	Shire plc (LSE: SHP, Nasdaq: SHPGY, TSX: SHQ)
	Today	Shire Ltd. (LSE: SHP, NASDAQ: SHPGY)
	Product	pharmaceutical
	Product 2	investment banking
	Index term	Shire–Takeda: investment, 201804–201901 acquisition $62.2b (incl debt approx $80b) for $30.33 per share in cash + 0.839 Takeda shares per share

Original document
accessed by [iito] on 2018-05-01

Record changed: 2023-06-05

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

More documents for Takeda (Group)

[1] VectorY B.V.. (11/8/22). "Press Release: VectorY Appoints Sander van Deventer as CEO and Makes Key Appointments to Its Leadership Team". Amsterdam....
[2] Takeda Pharmaceutical Co. Ltd.. (1/10/22). "Press Release: Takeda to Acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (gd) T Cell Engager Therapies Targeting Solid Tumors". Osaka & London....
[3] GammaDelta Therapeutics Ltd.. (10/27/21). "Press Release: Takeda to Acquire GammaDelta Therapeutics to Accelerate Development of Allogeneic gdT Cell Therapies Addressing Solid Tumors". Osaka & London....
[4] Panekès Partners SGR S.p.A.. (9/27/21). "Press Release: Panakès Partners Appoints Dr. Rob Woodman as Partner to Lead Biotech Investment". Milan....
[5] Transine Therapeutics Ltd.. (6/2/21). "Press Release: Transine Therapeutics Closes Extended Seed Funding of £9.1 Million Co-led by Takeda Ventures, Inc. and the Dementia Discovery Fund to Advance Its Novel Class of Therapeutic RNAs". Cambridge....
[6] Enterome S.A.. (9/23/20). "Press Release: Enterome Announces First Patient Dosed in Phase 2a Trial of Sibofimloc in Crohn’s Disease". Paris & Cambridge, MA....
[7] Engitix Ltd.. (8/25/20). "Press Release: Engitix Signs Collaboration and Licensing Agreement with Takeda to Develop Anti-Fibrotic Therapies in Advanced Liver Diseases". London....
[8] Evox Therapeutics Ltd.. (3/26/20). "Press Release: Evox Therapeutics and Takeda Sign Multi-target Rare Disease Collaboration"....
[9] GammaDelta Therapeutics Ltd.. (10/16/19). "Press Release: Adaptate Biotherapeutics Formed to Develop Antibody-based Therapies that Modulate Gamma Delta T-cells". London....
[10] Sosei Group Corporation (d/b/a Sosei Heptares). (8/5/19). "Press Release: Sosei Heptares and Takeda Enter into New Strategic Multi-target Research, Development and Commercialization Partnership". Tokyo & London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)